120 related articles for article (PubMed ID: 2875588)
1. Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.
Morita S; Izumi M; Nagataki S
Acta Endocrinol (Copenh); 1986 Aug; 112(4):517-22. PubMed ID: 2875588
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
Yokoyama N; Izumi M; Katamine S; Nagataki S
J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
[TBL] [Abstract][Full Text] [Related]
3. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
[TBL] [Abstract][Full Text] [Related]
4. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor.
Macchia E; Concetti R; Carone G; Borgoni F; Fenzi GF; Pinchera A
Clin Endocrinol (Oxf); 1988 Feb; 28(2):147-56. PubMed ID: 2901922
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
Uno C; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):193-205. PubMed ID: 2899523
[TBL] [Abstract][Full Text] [Related]
9. Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: correlation with thyrotropin binding-inhibiting antibodies.
Hensen J; Kotulla P; Finke R; Bogner U; Badenhoop K; Meinhold H; Schleusener H
J Clin Endocrinol Metab; 1984 Jun; 58(6):980-7. PubMed ID: 6144692
[TBL] [Abstract][Full Text] [Related]
10. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T
J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
[TBL] [Abstract][Full Text] [Related]
12. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
Zakarija M; Jin S; McKenzie JM
J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
[TBL] [Abstract][Full Text] [Related]
13. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
[TBL] [Abstract][Full Text] [Related]
14. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
[TBL] [Abstract][Full Text] [Related]
15. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
16. The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.
Bliddal H; Hegedüs L; Hansen JM; Bech K; van der Gaag R; Drexhage HA
Clin Endocrinol (Oxf); 1987 Jul; 27(1):75-84. PubMed ID: 2888551
[TBL] [Abstract][Full Text] [Related]
17. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
Macchia E; Fenzi GF; Monzani F; Lippi F; Vitti P; Grasso L; Bartalena L; Baschieri L; Pinchera A
Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
[TBL] [Abstract][Full Text] [Related]
18. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A
Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
[TBL] [Abstract][Full Text] [Related]
19. TSH binding-inhibiting antibodies in hyperthyroidism: relationship to clinical signs and hormone levels.
Benker G; Kotulla P; Kendall-Taylor P; Emrich D; Reinwein D
Clin Endocrinol (Oxf); 1989 Jan; 30(1):19-28. PubMed ID: 2570653
[TBL] [Abstract][Full Text] [Related]
20. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
